These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12920235)

  • 1. Identification of a novel glucocorticoid receptor mutation in budesonide-resistant human bronchial epithelial cells.
    Kunz S; Sandoval R; Carlsson P; Carlstedt-Duke J; Bloom JW; Miesfeld RL
    Mol Endocrinol; 2003 Dec; 17(12):2566-82. PubMed ID: 12920235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
    Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor alpha receptor- and Fas-associated FLASH inhibit transcriptional activity of the glucocorticoid receptor by binding to and interfering with its interaction with p160 type nuclear receptor coactivators.
    Kino T; Chrousos GP
    J Biol Chem; 2003 Jan; 278(5):3023-9. PubMed ID: 12477726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.
    Stevens A; Garside H; Berry A; Waters C; White A; Ray D
    Mol Endocrinol; 2003 May; 17(5):845-59. PubMed ID: 12569182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions.
    Wu J; Li Y; Dietz J; Lala DS
    Mol Endocrinol; 2004 Jan; 18(1):53-62. PubMed ID: 14551261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
    Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
    Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor.
    Boruk M; Savory JG; Haché RJ
    Mol Endocrinol; 1998 Nov; 12(11):1749-63. PubMed ID: 9817600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477H and hGRalphaG679S associated with generalized glucocorticoid resistance.
    Charmandari E; Kino T; Ichijo T; Zachman K; Alatsatianos A; Chrousos GP
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1535-43. PubMed ID: 16449337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo modulation of alpha- and beta-glucocorticoid-receptor mRNA in human bronchial epithelium.
    Korn SH; Wouters EF; Wesseling G; Arends JW; Thunnissen FB
    Am J Respir Crit Care Med; 1997 Mar; 155(3):1117-22. PubMed ID: 9116996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and -resistant human leukemic cells.
    Powers JH; Hillmann AG; Tang DC; Harmon JM
    Cancer Res; 1993 Sep; 53(17):4059-65. PubMed ID: 8358735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes.
    Ashraf J; Thompson EB
    Mol Endocrinol; 1993 May; 7(5):631-42. PubMed ID: 8316249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression level-dependent contribution of glucocorticoid receptor domains for functional interaction with STAT5.
    Doppler W; Windegger M; Soratroi C; Tomasi J; Lechner J; Rusconi S; Cato AC; Almlöf T; Liden J; Okret S; Gustafsson JA; Richard-Foy H; Starr DB; Klocker H; Edwards D; Geymayer S
    Mol Cell Biol; 2001 May; 21(9):3266-79. PubMed ID: 11287629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A somatic cell genetic method for identification of untargeted mutations in the glucocorticoid receptor that cause hormone binding deficiencies.
    Lee S; Duncan KA; Chou H; Chen D; Kohli K; Huang CF; Stallcup MR
    Mol Endocrinol; 1995 Jul; 9(7):826-37. PubMed ID: 7476966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators.
    Chatterjee VK; Madison LD; Mayo S; Jameson JL
    Mol Endocrinol; 1991 Jan; 5(1):100-10. PubMed ID: 1708098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between glucocorticoids and beta2-agonists: alpha and beta glucocorticoid-receptor mRNA expression in human bronchial epithelial cells.
    Korn SH; Wouters EF; Wesseling G; Arends JW; Thunnissen FB
    Biochem Pharmacol; 1998 Dec; 56(12):1561-9. PubMed ID: 9973176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of human UGT1A1 gene expression: activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1.
    Sugatani J; Nishitani S; Yamakawa K; Yoshinari K; Sueyoshi T; Negishi M; Miwa M
    Mol Pharmacol; 2005 Mar; 67(3):845-55. PubMed ID: 15557560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-dependent phosphorylation of the transcriptional coregulator GRIP1.
    Dobrovolna J; Chinenov Y; Kennedy MA; Liu B; Rogatsky I
    Mol Cell Biol; 2012 Feb; 32(4):730-9. PubMed ID: 22158970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities.
    Ding XF; Anderson CM; Ma H; Hong H; Uht RM; Kushner PJ; Stallcup MR
    Mol Endocrinol; 1998 Feb; 12(2):302-13. PubMed ID: 9482670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FLASH interacts with p160 coactivator subtypes and differentially suppresses transcriptional activity of steroid hormone receptors.
    Kino T; Ichijo T; Chrousos GP
    J Steroid Biochem Mol Biol; 2004 Dec; 92(5):357-63. PubMed ID: 15698540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the C terminus of the glucocorticoid receptor in hormone binding and agonist/antagonist discrimination.
    Zhang S; Liang X; Danielsen M
    Mol Endocrinol; 1996 Jan; 10(1):24-34. PubMed ID: 8838142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.